Etiket: Gilead
An antiretroviral developed by Gilead based on the molecule lenacapavir could be a game-changer against AIDS
A treatment considered very promising against AIDS, which costs about $40,000 per person each year, could fall to around $40 in a generic version, according to an estimate unveiled Tuesday…
personalities ask the Gilead laboratory to lower the prices of a promising treatment
Approved since 2022 by American and European health authorities, it is marketed under the name Sunlenca. It only requires two injections per year in people infected with the virus. But…
personalities ask the Gilead laboratory to lower the prices of a promising treatment
Approved since 2022 by American and European health authorities, it is marketed under the name Sunlenca. It only requires two injections per year in people infected with the virus. But…
HIV | The Gilead group singled out for accessibility to a new treatment
(Paris) Several personalities – scientists, political leaders, celebrities – called on Thursday the pharmaceutical group Gilead to make available a treatment deemed promising in the fight against HIV infections. Published…